Malignancy in systemic lupus erythematosus

Arthritis and Rheumatism

Volumn 39, Issue 6, 1996, Pages 1050-1054

  Abu Shakra, Mahmoud ^a,b   Gladman, Dafna D ^c,d   Urowitz, Murray B ^c  

^a UNIVERSITY OF TORONTO   (Canada)

^b BEN GURION UNIVERSITY OF THE NEGEV   (Israel)

^c UNIVERSITY HEALTH NETWORK   (Canada)

^d TORONTO WESTERN HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; AUTOPSY; CANCER; CANCER INCIDENCE; CANCER RISK; FEMALE; HISTOLOGY; HUMAN; MAJOR CLINICAL STUDY; MALE; NONHODGKIN LYMPHOMA; PRIORITY JOURNAL; PROSPECTIVE STUDY; RHEUMATOID ARTHRITIS; SCHOOL CHILD; SYSTEMIC LUPUS ERYTHEMATOSUS; SYSTEMIC SCLEROSIS;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ARTHRITIS, RHEUMATOID; CHILD; FEMALE; HUMANS; INCIDENCE; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; MIDDLE AGED; NEOPLASMS; ONTARIO; PROSPECTIVE STUDIES; RISK FACTORS; SCLERODERMA, SYSTEMIC;

EID: 0029897564     PISSN: 00043591     EISSN: None     Source Type: Journal    
DOI: 10.1002/art.1780390625     Document Type: Article

References (18)

1. Sela O, Shoenfeld Y: Cancer in autoimmune diseases. Semin Arthritis Rheum 18:77-87, 1988
2. Abu-Shakra M, Guillemin F, Lee P: Cancer in systemic sclerosis. Arthritis Rheum 36:460-464, 1993
3. Matteson EL, Hickey AR, McGuire L, Tilson HH, Urowitz MB, Members of the Rheumatoid Arthritis Azathioprine Registry Steering Committee: Occurrence of neoplasia in patients with rheumatoid arthritis enrolled in a DMARD registry. J Rheumatol 18:809-814, 1991
4. Black KA, Zilko PJ, Dawkins RL, Armstrong BK, Mastaglia GL: Cancer in connective tissue disease. Arthritis Rheum 25:1130-1133, 1982
5. Lewis RB, Castor CW, Knisley RE, Bole GG: Frequency of neoplasia in systemic lupus erythematosus and rheumatoid arthritis. Arthritis Rheum 19:1256-1260, 1976
6. Canoso JJ, Cohen AS: Malignancy in a series of 70 patients with systemic lupus erythematosus. Arthritis Rheum 17:383-388, 1974
7. Bhalla R, Ajmani HS, Kim WW, Swedler WI, Lazarevic MB, Skosey JL: Systemic lupus erythematosus and Hodgkin's lymphoma. J Rheumatol 20:1316-1320, 1993
8. Menon S, Snaith ML, Isenberg D: The association of malignancy with SLE: an analysis of 150 patients under long-term review. Lupus 2:177-181, 1993
9. Petterson T, Pukkala E, Teppo L, Friman C: Increased risk of cancer in patients with systemic lupus erythematosus. Ann Rheum Dis 51:437-439, 1992
10. Tan EM, Cohen AS, Fries JF, Masi AT, McShane DJ, Rothfield NF, Schaller JG, Talal N, Winchester RJ: The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 25:1272-1277, 1982
11. Statistics Canada: Cancer in Canada 1985, 1986. Health Rep 3 (suppl 8):1-215, 1991
12. Breslow NE, Day NE: Rates and rate standardization. In, Statistical Methods in Cancer Research: The Design and Analysis of Cohort Studies. Vol. II. Lyons, International Agency for Research on Cancer, 1987
13. Gardner MJ, Altman DG: Statistics with Confidence. London, BMJ, 1989
14. Gladman DD, Urowitz MB: Systemic lupus erythematosus: clinical features. In, Primer on the Rheumatic Diseases. Tenth edition. Edited by HR Schumacher Jr, JH Klippel, WJ Koopman. Atlanta, Arthritis Foundation, 1993
15. Jordon E, Burnstein SL, Calabro JJ, Henderson ES: Multiple myeloma complicating the course of seronegative systemic lupus erythematosus. Arthritis Rheum 21:260-263, 1978
16. Deaton JG, Levin WF: Systemic lupus erythematosus and acute myeloblastic leukemia: report of their coexistence and a survey of possible associating features. Arch Intern Med 120:345-348, 1967
17. Elliot RW, Essenhigh DM, Morley AR: Cyclophosphamide treatment of systemic lupus erythematosus: risk of bladder cancer exceeds benefit. BMJ 284:1160-1161, 1982
18. Via CS, Handwerger BS: B-cell and T-cell function in systemic lupus erythematosus. Curr Opin Rheumatol 5:570-574, 1993